Walleye Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$16.4K 4893
2025
Q4
$16.4K Hold
100
﹤0.01% 4263
2025
Q3
$13.4K Sell
100
-500
-83% -$60.7K ﹤0.01% 4256
2025
Q2
$74.6K Sell
600
-100
-14% -$12.7K ﹤0.01% 3903
2025
Q1
$89.1K Sell
700
-21,200
-97% -$3.26M ﹤0.01% 3666
2024
Q4
$3.15M Sell
21,900
-1,400
-6% -$201K 0.01% 1392
2024
Q3
$3.47M Sell
23,300
-12,300
-35% -$1.76M 0.01% 1459
2024
Q2
$4.49M Sell
35,600
-6,900
-16% -$1.08M 0.01% 1367
2024
Q1
$7.82M Buy
42,500
+31,500
+286% +$6M 0.01% 987
2023
Q4
$1.98M Sell
11,000
-10,000
-48% -$1.56M ﹤0.01% 1788
2023
Q3
$3.34M Buy
21,000
+13,200
+169% +$2.16M 0.01% 1335
2023
Q2
$1.1M Buy
+7,800
New +$1.25M ﹤0.01% 1775
2020
Q1
Sell
-2,800
Closed -$259K 1523
2019
Q4
$259K Sell
2,800
-17,800
-86% -$1.5M 0.02% 1003
2019
Q3
$1.58M Sell
20,600
-30,500
-60% -$2.67M 0.09% 290
2019
Q2
$4.39M Buy
51,100
+45,000
+738% +$3.07M 0.48% 18
2019
Q1
$360K Buy
+6,100
New +$351K 0.06% 518

Other funds holding RGEN

Walleye Capital's RGEN Position: Q1 2026 in Review

Walleye Capital sold out of Repligen (RGEN) in Q1 2026, closing a stake of 417,110 shares — an estimated $68.3M sold.

Walleye Capital first reported a position in RGEN in Q2 2019 and held it in 15 quarters. The position peaked at $68.3M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Walleye Capital reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 417,110 Repligen shares in Q1 2026, an estimated $68.3M.
  • Walleye Capital first reported a position in Repligen in Q2 2019 and held it in 15 quarters.
  • Walleye Capital's Repligen position peaked at $68.3M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.